Location: Home
  • search
  • go
  • Relate News
  • 3/22/2022China Biotech Firms Stunned by US Drug Trial U-Turn (Asia Financial)
  • 3/21/2022As AZ Sounds the Slowdown Alarm in China, Jefferies Beats the Drum for...
  • 3/21/2022Bavarian Nordic and Nuance Pharma Enter License for RSV Vaccine for ...
  • 3/21/2022China's Triastek and Siemens Strive to Accelerate Digital Transformati...
  • 3/20/2022FT: China Plans Audit Concession in Face of US Delisting Threat
  • 3/18/2022Lynk and Simcere Enter Strategic Commercialization Partnership in Chin...
  • 3/18/2022EdiGene Licenses from BCH the Methods and Compositions for Boosting Fe...
  • 3/18/2022Sinohealth: Chinese Public Hospital Drug Market Up 10.1% in 2021
  • 3/18/2022Drug R&D and Product Registration News Digest March 2022 (3)
  • 3/18/2022Recent Executive Moves
  • 3/17/2022Five Chinese Firms Agree to Make Generic Version of Pfizer's Oral COVI...
  • 3/16/2022Adagene, Merck Gets FDA Blessing P1b/2 Trial of ADG126/Keytruda Combo
  • 3/16/2022Pfizer COVID-19 Pill Added to Pandemic Treatment Guidelines in China ...
  • 3/16/2022China Resources Licenses Global Rights of Ab Studio's COVID Antibody ...
  • 3/16/2022PharmCube: An Analysis of NDAs in China
  • 3/16/2022Another Strike for Biotech: China (Evaluate)
  • 3/15/2022Biopharma Patents in China: Litigation, Licensing, and Patent Linkage ...
  • 3/14/2022China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)
  • 3/14/2022Chinese Investors' Interest In Cell And Gene Therapy Remains Strong
  • 3/14/2022CDE Releases the Draft Guidelines for Clinical Trial of Improvement Ch...
  • 3/11/2022Pharma CMO Stevanato Group Expands Capacity in China with New Facility
  • 3/11/2022NMPA Issues the List of Reference Formulations for GQCE Studies (52nd ...
  • 3/11/2022CDE Solicits Comments on the Draft Procedures for Adjustment of Publis...
  • 3/11/2022CDE Solicits Comments on the Draft Technical Guidelines for Protocol C...
  • 3/11/2022CDE Solicits Comments on Two Draft TCM Registration Guidelines
  • 3/11/2022Recent Executive Moves
  • 3/11/2022Drug R&D and Product Registration News Digest March 2022 (2)
  • 3/10/2022AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...
  • 3/10/2022SEC Sets Clock for Delisting Chinese Companies Over US Audit Demand (U...
  • 3/10/2022Zai Lab Revenue Triples, As It Struggles to Break Cycle of Mounting Lo...
  • Page:169/797 Total number of articles:23898: [First][<<] [167] [168] [169] [170] [171] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group